118 related articles for article (PubMed ID: 22886215)
41. Expression of indoleamine 2,3-dioxygenase and correlation with pathological malignancy in gliomas.
Mitsuka K; Kawataki T; Satoh E; Asahara T; Horikoshi T; Kinouchi H
Neurosurgery; 2013 Jun; 72(6):1031-8; discussion 1038-9. PubMed ID: 23426156
[TBL] [Abstract][Full Text] [Related]
42. Overexpression of XIAP expression in renal cell carcinoma predicts a worse prognosis.
Mizutani Y; Nakanishi H; Li YN; Matsubara H; Yamamoto K; Sato N; Shiraishi T; Nakamura T; Mikami K; Okihara K; Takaha N; Ukimura O; Kawauchi A; Nonomura N; Bonavida B; Miki T
Int J Oncol; 2007 Apr; 30(4):919-25. PubMed ID: 17332931
[TBL] [Abstract][Full Text] [Related]
43. The significance of thymidine phosphorylase/platelet-derived endothelial cell growth factor activity in renal cell carcinoma.
Mizutani Y; Wada H; Yoshida O; Fukushima M; Kawauchi A; Nakao M; Miki T
Cancer; 2003 Aug; 98(4):730-6. PubMed ID: 12910516
[TBL] [Abstract][Full Text] [Related]
44. High levels of thymidine phosphorylase as an independent prognostic factor in renal cell carcinoma.
Takayama T; Mugiya S; Sugiyama T; Aoki T; Furuse H; Liu H; Hirano Y; Kai F; Ushiyama T; Ozono S
Jpn J Clin Oncol; 2006 Sep; 36(9):564-9. PubMed ID: 16861722
[TBL] [Abstract][Full Text] [Related]
45. Significance of heat shock protein-27 expression in patients with renal cell carcinoma.
Erkizan O; Kirkali G; Yörükoğlu K; Kirkali Z
Urology; 2004 Sep; 64(3):474-8. PubMed ID: 15351573
[TBL] [Abstract][Full Text] [Related]
46. The expression of ketohexokinase is diminished in human clear cell type of renal cell carcinoma.
Hwa JS; Kim HJ; Goo BM; Park HJ; Kim CW; Chung KH; Park HC; Chang SH; Kim YW; Kim DR; Cho GJ; Choi WS; Kang KR
Proteomics; 2006 Feb; 6(3):1077-84. PubMed ID: 16372272
[TBL] [Abstract][Full Text] [Related]
47. Impact of several histopathological prognosticators and local tumour extension on oncological outcome in pT3b/c N0M0 renal cell carcinoma.
Roos FC; Weirich J; Victor A; Elsässer A; Brenner W; Biesterfeld S; Hampel C; Thüroff JW
BJU Int; 2009 Aug; 104(4):461-9. PubMed ID: 19338563
[TBL] [Abstract][Full Text] [Related]
48. Indoleamine 2,3-dioxygenase is differentially expressed by different white blood cell populations of rhesus macaques (Macaca mulatta).
Lei N; Wang Y; Zhang WJ; Duan JZ; Yang GB
J Med Primatol; 2013 Aug; 42(4):192-203. PubMed ID: 23679126
[TBL] [Abstract][Full Text] [Related]
49. Proapoptotic activity of indoleamine 2,3-dioxygenase expressed in renal tubular epithelial cells.
Mohib K; Guan Q; Diao H; Du C; Jevnikar AM
Am J Physiol Renal Physiol; 2007 Sep; 293(3):F801-12. PubMed ID: 17609291
[TBL] [Abstract][Full Text] [Related]
50. hTERT expression in sporadic renal cell carcinomas.
Paradis V; Bièche I; Dargère D; Bonvoust F; Ferlicot S; Olivi M; Lagha NB; Blanchet P; Benoît G; Vidaud M; Bedossa P
J Pathol; 2001 Sep; 195(2):209-17. PubMed ID: 11592100
[TBL] [Abstract][Full Text] [Related]
51. Prognostic significance of multidrug-resistance protein (MDR-1) in renal clear cell carcinomas: a five year follow-up analysis.
Mignogna C; Staibano S; Altieri V; De Rosa G; Pannone G; Santoro A; Zamparese R; D'Armiento M; Rocchetti R; Mezza E; Nasti M; Strazzullo V; Montanaro V; Mascolo M; Bufo P
BMC Cancer; 2006 Dec; 6():293. PubMed ID: 17177989
[TBL] [Abstract][Full Text] [Related]
52. Immunological role of indoleamine 2,3-dioxygenase in rat liver allograft rejection and tolerance.
Lin YC; Chen CL; Nakano T; Goto S; Kao YH; Hsu LW; Lai CY; Jawan B; Cheng YF; Tateno C; Yoshizato K
J Gastroenterol Hepatol; 2008 Jul; 23(7 Pt 2):e243-50. PubMed ID: 17645734
[TBL] [Abstract][Full Text] [Related]
53. Expression of the EphA1 protein is associated with Fuhrman nuclear grade in clear cell renal cell carcinomas.
Wang X; Liu Y; Cao G; Zhang X; Xu H; Xu H; Wang J
Int J Clin Exp Pathol; 2015; 8(6):6821-7. PubMed ID: 26261568
[TBL] [Abstract][Full Text] [Related]
54. Indoleamine 2,3-dioxygenase (IDO) expression in lung cancer.
Karanikas V; Zamanakou M; Kerenidi T; Dahabreh J; Hevas A; Nakou M; Gourgoulianis KI; Germenis AE
Cancer Biol Ther; 2007 Aug; 6(8):1258-62. PubMed ID: 17700060
[TBL] [Abstract][Full Text] [Related]
55. Indoleamine 2,3 dioxygenase as a prognostic and follow-up marker in melanoma. A comparative study with LDH and S100B.
de Lecea MV; Palomares T; Al Kassam D; Cavia M; Geh JLC; de Llano P; Muñiz P; Armesto D; Martinez-Indart L; Alonso-Varona A
J Eur Acad Dermatol Venereol; 2017 Apr; 31(4):636-642. PubMed ID: 27633490
[TBL] [Abstract][Full Text] [Related]
56. Chemoresistance was correlated with elevated expression and activity of indoleamine 2,3-dioxygenase in breast cancer.
Zhao Y; Wei L; Liu J; Li F
Cancer Chemother Pharmacol; 2020 Jan; 85(1):77-93. PubMed ID: 31844921
[TBL] [Abstract][Full Text] [Related]
57. The clinical significance of PYCR1 expression in renal cell carcinoma.
Weijin F; Zhibin X; Shengfeng Z; Xiaoli Y; Qijian D; Jiayi L; Qiumei L; Yilong C; Hua M; Deyun L; Jiwen C
Medicine (Baltimore); 2019 Jul; 98(28):e16384. PubMed ID: 31305441
[TBL] [Abstract][Full Text] [Related]
58. Expression of Indoleamine 2,3-Dioxygenase Gene Is a Feature of Poorly Differentiated Non-muscle-invasive Urothelial Cell Bladder Carcinomas.
Hudolin T; Mengus C; Coulot J; Kastelan Z; El-Saleh A; Spagnoli GC
Anticancer Res; 2017 Mar; 37(3):1375-1380. PubMed ID: 28314306
[TBL] [Abstract][Full Text] [Related]
59. [Effects of Toll-like receptors on indoleamine 2, 3-dioxygenase mRNA levels in human trophoblast HTR-8/SVneo cells].
Xu W; Yang G; Duan J; Wang Y; Yao W; Liu X; Chen X; Ding Y; Wang Y; He J
Nan Fang Yi Ke Da Xue Xue Bao; 2013 Nov; 33(11):1559-64. PubMed ID: 24273253
[TBL] [Abstract][Full Text] [Related]
60. A novel immunohistochemical score to predict early mortality in acute myeloid leukemia patients based on indoleamine 2,3 dioxygenase expression.
Mangaonkar A; Mondal AK; Fulzule S; Pundkar C; Park EJ; Jillella A; Kota V; Xu H; Savage NM; Shi H; Munn D; Kolhe R
Sci Rep; 2017 Oct; 7(1):12892. PubMed ID: 29038460
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]